CAR-T Buying Bonanza, bluebird bio Is Next On The Acquisition Block – Seeking Alpha
Seeking Alpha |
CAR–T Buying Bonanza, bluebird bio Is Next On The Acquisition Block
Seeking Alpha These diseases are: adrenoleukodystrophy, Beta Thalassemia, and sickle cell disease. These targeted indications are treated by using Bluebird's gene therapy technology. The beauty of Bluebird's technology is that it can be applied to CAR-T therapy as … |
